1. Market Research
  2. > Healthcare Market Trends
Real World Evidence Solutions Market by Component, Therapeutic Area, End User - Global Forecast to 2023

Real World Evidence Solutions Market: Global Forecast until 2023

  • July 2018
  • 158 pages
  • ID: 5474776
In this report:
India's digital connectivity is expected to grow from ##% in 2014 to ##% in 2034, with rural Internet users increasing by ##% annually.
According to the Italian National Institute of Statistics (ISTAT), in 2016, healthcare spending accounted for ##.##% of the GDP in Italy, ##% of which was funded by public sources.


Table of Contents

Search Inside

The overall real world evidence market forecasted to grow at a compound annual growth rate (CAGR) of 14.30 percent.

The overall real-world evidence market is estimated to grow $1348.10M by 2023 from $689.90M in 2018, at a compound annual growth rate (CAGR) of 14.3% during the forecast horizon. The rise of this market is mainly driven by the growing geriatric population (and the subsequent rise in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent growth in development costs). Nevertheless, the reluctance to rely on real-world studies and the lack of universally accepted methodological standards for data collection are selecting the increase of this market.

The services segment is expected to record the maximal compound annual growth rate (CAGR) during the outlook period.

On the basis of component, the real world evidence market is divided into data sets and services.The services segment is projected to register the highest CAGR (Compound annual growth rate) during the estimate period.

The high increase rate of this segment is primarily due to the increasing need to convert info into actionable evidence, increasing need to minimize drug development delays, and availability of big amounts of healthcare data are the main factors driving market increase in this industry segment.

Pharmaceutical & medical device companies segment forecasted to grow at the highest compound annual growth rate (CAGR) during 2018 to 2023.

Established on final user, the real-world evidence market is mostly broken down into pharmaceutical & medical device firms, healthcare providers, healthcare payers, and other end users (academic institutions, patient advocacy groups, and health technology assessment agencies).The pharmaceutical & biopharmaceutical companies segment is the quickest-growing segment in the real world evidence market during the outlook period.

The increasing demand to assess comparative effectiveness of drugs in actual, real-world use and the value or economic impact from the use of new or existing drugs are the main factors driving the rise of the real world evidence market for pharmaceutical & medical device firms.

Asia-Pac is forecasted to witness the highest increase during the estimate period.

North America (NA) held the biggest share of the overall real world evidence market in 2017. On the other hand, the APAC area is forecast to witness the more important Compound annual growth rate during the outlook period, due to the growing government initiatives for the adoption of RWE studies, increasing burden of chronic diseases, growing demand for better healthcare services, and the growing geriatric population in the Asia Pacific area.

Break of primary members taking part was as mentioned below:

• By Company category - Tier 1 - 25.0 percent, Tier 2 - 50.0 percent and Tier 3 - 25.0 percent

• By Description - C-suite - 25.0 percent, D-level - 37.0 percent, Others - 38.0 percent

• By Area - North America continent - 25.0 percent, Europe (EU) - 25.0 percent, Asia Pacific (APAC) - 37.0 percent, Rest of World - 13.0 percent

The main players in the overall real world evidence market are IQVIA, International Business Machines (NYSE:IBM), ICON, PAREXEL, Pharmaceutical Product Development, Optum, Cognizant, Oracle Corporation (NYSE:ORCL), SAS, Syneos Health, Anthem, Clinigen Group, Palantir Technologies, and Flatiron Health.

Segment Research

The market research examines the different real world evidence and their adoption pattern.It aims at evaluating the market value and future increase potential of the overall real world evidence market for distinct segments including by component, therapeutic area, end-user, and area.

The industry report also comprises a detailed competitive analysis of the top players in this sector together with their company descriptions, product offerings, latest developments, and key industries strategies.

Reasons to Buy the Report

The study will increase established companies as well as new entrants/smaller companies to measure the pulse of the sector, which in turn would benefit them, collect a greater share. Companies obtaining the analysis could use one or any combination of the below-mentioned five strategies for strengthening the market.

This industry report offers business insights on these pointers:

• Market Uptake: Exhaustive data on product types provided by the top actors in the overall real world evidence market. The market research examines the overall real world evidence market by component, therapeutic area, final user, and area

• Service Development/Innovative products: In-depth understanding on upcoming trends and service launches in the overall real world evidence market

• Market Development: Highlighted information on the lucrative emerging regions by component, therapeutic area, end-user, and area

• industry diversification: Complete information about new services, increasing geographies, and recent evolutions in the overall real world evidence market

• opposing assessment: Detailed assessment of market shares, increase strategies, and services of leading actors in the overall real world evidence market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • $ 7995
  • Industry report
  • September 2018
  • by GlobalData

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EUSummaryMarket access of oncology medicines is increasingly challenging due to the rising cost of new and innovative medicines, more ...

Healthcare Industry Transformation

Healthcare Industry Transformation

  • $ 7500
  • Industry report
  • August 2018
  • by IDC

This IDC Market Perspective summarizes and give updates on the trends surrounding the healthcare market in Latin America (LATAM). This study discusses the developments and the dynamics across LATAM countries, ...

Asia-Pacific Cranio Maxillofacial Fixation (CMF) Market Outlook to 2025

Cranio Maxillofacial Fixation (CMF) in Asia-Pacific to 2025

  • $ 5995
  • Industry report
  • July 2018
  • by GlobalData

Asia-Pacific Cranio Maxillofacial Fixation (CMF) Market Outlook to 2025SummaryGlobalData’s new report, Asia-Pacific Cranio Maxillofacial Fixation (CMF) Market Outlook to 2025, provides key market data ...


Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on